Newlink Genetics reported $8.05M in Operating Expenses for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Agenus AGEN:US USD 64.42M 1.07M
Bristol Myers Squibb BMY:US USD 8.75B 552M
Capricor Therapeutics CAPR:US USD 8.07M 747.57K
Celldex Therapeutics CLDX:US USD 28.1M 8.46M
Eli Lilly And LLY:US USD 5.27B 12.8M
Idera Pharmaceuticals IDRA:US USD 9.38M 4.01M
Intrexon XON:US USD 24.34M 2.74M
Merk MRK:US USD 10.97B 1.31B
Nektar Therapeutics NKTR:US USD 77.93M 96.49M
Newlink Genetics NLNK:US USD 8.05M 280K
Pfizer PFE:US USD 13.23B 2.41B
Prothena PRTA:US USD 51.85M 7.33M
Sarepta Therapeutics SRPT:US USD 487.06M 42.45M
YTE INCY:US USD 684.93M 27.96M